| Literature DB >> 33947944 |
Nesreen Hamad1, Ryoma Yoneda2, Masatomo So3, Riki Kurokawa2, Takashi Nagata1,4, Masato Katahira5,6.
Abstract
Fused in sarcoma/translocated in liposarcoma (FUS/TLS) is a multitasking RNA/DNA binding protein. FUS aggregation is implicated in various neurodegenerative diseases. RNA was suggested to modulate phase transition of FUS. Here, we found that FUS transforms into the amorphous aggregation state as an instant response to the shear stress caused by usual pipetting even at a low FUS concentration, 100 nM. It was revealed that non-coding RNA can suppress the transformation of FUS into aggregates. The suppressive effect of RNA on FUS aggregation is sequence-dependent. These results suggested that the non-coding RNA could be a prospective suppressor of FUS aggregation caused by mechanistic stress in cells. Our finding might pave the way for more research on the role of RNAs as aggregation inhibitors, which could facilitate the development of therapies for neurodegenerative diseases.Entities:
Year: 2021 PMID: 33947944 DOI: 10.1038/s41598-021-89075-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379